Amelioration of levodopa-induced cognitive impairments by nicotinic therapies in a model of early Parkinson's disease

被引：0
|
作者：
Schneider, J. S.
Decamp, E.
机构：
来源：
MOVEMENT DISORDERS | 2008年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
940
引用
收藏
页码：S307 / S307
页数：1
相关论文
共 50 条
  • [41] Handicap in Parkinson's disease with levodopa-induced motor complications
    Coelho, M.
    Correia Guedes, L.
    Pita Lobo, P.
    Abreu, D.
    Albuquerque, L.
    Pereira, J. M.
    Rosa, M. M.
    Ferreira, J. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 439 - 439
  • [42] Risperidone and suppression of levodopa-induced dyskinesia in Parkinson's disease
    Parsa, MA
    Greenaway, HM
    Mangat, TS
    BIOLOGICAL PSYCHIATRY, 1999, 45 (08) : 137S - 137S
  • [43] Levodopa-induced dyskinesias in Parkinson's disease: Is sensitization reversible?
    Bejjani, BP
    Arnulf, I
    Demeret, S
    Damier, P
    Bonnet, AM
    Houeto, JL
    Agid, Y
    ANNALS OF NEUROLOGY, 2000, 47 (05) : 655 - 658
  • [44] Parkinson's disease: Levodopa-induced dyskinesia and signal transduction
    Santini, Emanuela
    Valjent, Emmanuel
    Fisone, Gilberto
    FEBS JOURNAL, 2008, 275 (07) : 1392 - 1399
  • [45] Surgical Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease
    Krishnan, Syam
    Pisharady, Krishnakumar Kesava
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2017, 20 (03) : 199 - 206
  • [46] Force overflow and levodopa-induced dyskinesias in Parkinson's disease
    Wenzelburger, R
    Zhang, BR
    Pohle, S
    Klebe, S
    Lorenz, D
    Herzog, J
    Wilms, H
    Deuschl, G
    Krack, P
    BRAIN, 2002, 125 : 871 - 879
  • [47] Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias
    Cheshire, Perdita
    Ayton, Scott
    Bertram, Kelly L.
    Ling, Helen
    Li, Abi
    McLean, Catriona
    Halliday, Glenda M.
    O'Sullivan, Sean S.
    Revesz, Tamas
    Finkelstein, David I.
    Storey, Elsdon
    Williams, David R.
    MOVEMENT DISORDERS, 2015, 30 (06) : 796 - 804
  • [48] Idazoxan is ineffective for levodopa-induced dyskinesias in Parkinson's disease
    Manson, AJ
    Iakovidou, E
    Lees, AJ
    MOVEMENT DISORDERS, 2000, 15 (02) : 336 - 337
  • [49] Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease
    Carpentier, AF
    Bonnet, AM
    Vidailhet, M
    Agid, Y
    NEUROLOGY, 1996, 46 (06) : 1548 - 1551
  • [50] Levodopa-induced hyperhomocysteinemia and cardiovascular dysfunction in Parkinson's disease
    Zesiewicz, TA
    Giunta, B
    Hauser, RA
    Hoffman, M
    Wallach, P
    Sullivan, KL
    MOVEMENT DISORDERS, 2004, 19 : S213 - S214
12345